Vitamin D Augmentation of Tekturna (Aliskiren) in Hypertension

Status unconfirmed · Phase 4 · Has a placebo group

Conditions studied: Hypertension

In brief

In this research study, the goal is to find out if a currently FDA-approved medication called Tekturna(Aliskiren) along with the addition of Vitamin D will lower blood pressure and improve heart function in the African American population. High blood pressure occurs earlier in life in African Americans, is more severe, and is associated with greater organ damage in relation to uncontrolled hypertension. Having low levels of Vitamin D is also very common in the African American population. Research has shown that there may be a link between low Vitamin D levels and the ability of high blood pressure medications to be fully effective.

Key facts

Study ID

NCT01472796

Run by

Wayne State University

People needed

92

Starts

2011-07-01

Expected to finish

2014-03-01

Last updated by the study team

2011-11-16

Who can join

Age: 30 and older, up to 74. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ages 30-74
• Systolic Blood Pressure 140-159 mm Hg and Diastolic Blood Pressure <100 OR Diastolic Blood Pressure 90-99mm Hg and Systolic Blood Pressure <160mm Hg
• Vitamin D deficiency: Serum 25-OH D >= 10 ng/ml (25 nmol/L) to < 20 ng/ml (50 nmol/L)
• Not using any antihypertensive medication(s) for the previous 3 months

You may not qualify if…

• Cancer(other than skin) known HIV or other medical condition that might limit life expectancy.
• Pregnant or nursing
• Know adverse reactions to DRI's
• Hepatitis or liver enzyme elevations > 1.5x normal
• Estimated glomerular filtration rate (EGFR) <50 ml/min/1.7m2
• Diabetes Mellitus
• Serum calcium > 10.5 mg/dl or history of hypercalcemia
• History of primary hyperparathyroidism
• Sarcoidosis or other granulomatous disease
• Taking > 500 mg/d of supplemental elemental calcium
• Taking any drugs that decrease absorption of vitamin D, ex:xenical
• Taking the drug cyclosporine
• Taking any antihypertensive medications in the previous 3 months
• History of kidney stones
• Planning to move > 50 miles in the next 9 months

Where it is running

• Wayne State University, 4201 St. Antoine — Detroit, Michigan, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.